文献速递头颈外科

头颈癌相关颈动脉破裂综合征的颅外/颅内血管搭桥治疗

Extracranial/Intracranial Vascular Bypass in the Treatment of Head and Neck Cancer - Related Carotid Blowout Syndrome.
PubMed 文献 · Laryngoscope · 2021-02-11

ECA出血均行血管内栓塞;ICA/CCA出血者9例行EC/IC搭桥、1例行栓塞、3例行支架。ICA/CCA相关CBS患者生存期更长、再出血风险更低,可能与更多采用EC/IC搭桥作为确定性治疗有关。

要点

  • ECA相关CBS均采用血管内栓塞治疗。
  • ICA/CCA相关CBS中9/12例行EC/IC血管搭桥。
  • ICA/CCA相关CBS生存期更长、再出血风险更低。

核心结论

  • 对于ICA/CCA相关CBS患者,若血流动力学更稳定、预期生存期更长,优先选择EC/IC血管搭桥。

主要发现

  • ECA出血患者均行血管内栓塞治疗。
  • 12例ICA/CCA出血患者中,9例行EC/IC搭桥,1例行血管内栓塞,3例行血管内支架。
  • ECA相关CBS患者中位生存6个月,90天、1年、2年生存率分别为67.1%、44.7%、33.6%;1个月、6个月、2年再出血风险分别为7.1%、20.0%、31.6%。
  • ICA/CCA相关CBS患者中位生存22.5个月,90天、1年、2年生存率分别为92.3%、71.8%、41.0%;1个月、6个月、2年再出血风险分别为7.7%、15.4%、15.4%。

临床怎么用

  • 对ICA/CCA相关CBS且血流动力学稳定、预期生存较长的患者,可优先考虑EC/IC血管搭桥。

局限性

  • 本研究为回顾性病例系列,证据等级为4级。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVE/HYPOTHESIS: To investigate the endovascular intervention or extracranial/intracranial (EC/IC) vascular bypass in the management of patients with head and neck cancer-related carotid blowout syndrome (CBS). STUDY DESIGN: Retrospective case series. METHODS: Retrospective analysis of clinical data of patients with head and neck cancer-related CBS treated by endovascular intervention and/or EC/IC vascular bypass, analysis of its bleeding control, neurological complications, and survival results. RESULTS: Thrity-seven patients were included. Twenty-five were associated with external carotid artery (ECA); twelve were associated with internal or common carotid artery (ICA/CCA). All patients with ECA hemorrhage were treated with endovascular embolization. Of the 12 patients with ICA/CCA hemorrhage, 9 underwent EC/IC bypass, 1 underwent endovascular embolization, and 3 underwent endovascular stenting. For patients with ECA-related CBS, the median survival was 6 months, and the 90-day, 1-year, and 2-year survival rates were 67.1%, 44.7%, and 33.6%, respectively; the estimated rebleeding risk at 1-month, 6-month, and 2-year was 7.1%, 20.0%, and 31.6%, respectively. For patients with ICA/CCA-related CBS, the median survival was 22.5 months, and the 90-day, 1-year, and 2-year survival rates were 92.3%, 71.8%, and 41.0%, respectively; the estimated rebleeding risk at 1 month, 6 months, and 2 years is 7.7%,15.4%, and 15.4%, respectively. ICA/CCA-related CBS patients have significantly longer survival time and lower risk of rebleeding, which may be related to the more use of EC/IC vascular bypass as a definite treatment. CONCLUSIONS: For patients with ICA/CCA-related CBS, if there is more stable hemodynamics, longer expected survival, EC/IC vascular bypass is preferred. LEVEL OF EVIDENCE: 4 Laryngoscope, 131:1548-1556, 2021.

来源:Laryngoscope,查看原文。版权归原作者所有。

引用

  1. Wu PA, Yuan GY, Zhou RM, et al. Extracranial/Intracranial Vascular Bypass in the Treatment of Head and Neck Cancer - Related Carotid Blowout Syndrome. Laryngoscope. 2021. PMID: 33571390. doi:10.1002/lary.29427

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。